P221 ANKLE BRACHIAL INDEX AND ASSOCIATION WITH CHRONIC KIDNEY DISEASE IN THE H3 AFRICA KIDNEY DISEASE RESEARCH NETWORK
Background and Objective: Abnormal ankle brachial index (ABI) is common in patients with chronic kidney disease (CKD). We evaluated the association of ABI, a non-invasive tool to evaluate peripheral arterial disease and arterial stiffness, with CKD among West Africans enrolled in the H3Africa Kidney Disease Research Network (H3AKDRN). Methods: We recruited 9206 participants (5356 with CKD), from Ghana and Nigeria in the H3AKDRN, a multinational case-control study. CKD was defined as estimated glomerular filtration rate of <60 ml/min/1.73m2 and/or albuminuria as albumin/creatinine ratio >3.0 mg/mmol (>30 mg/g) for ≥3months. ABI was divided into low (≤0.9), normal (0.91 – 1.3), and high (>1.3). We assessed low ABI, a marker of peripheral artery disease, and high ABI, the marker of arterial stiffness. We determined association of ABI with CKD by multivariate logistic regression. Results: The mean age of participants was 45.8±15.36 years and 56.3% were males. The prevalence of low ABI was higher in CKD group (32%% versus 16% (control), p=0.013). The prevalence of high ABI was also higher in CKD (15% versus 10.9% (control), p = 0.01). Patients with CKD and low ABI have reduced BMI, low haemoglobin, higher systolic BP and increased albuminuria. Male gender, history of hypertension and diabetes were independently associated with CKD. Higher BMI was associated with reduced odds of CKD (p = < 0.03). After adjustment for covariates, low ABI was associated with CKD, with 26% increased odd (aOR 1.26 (CI, 1.01 – 1.56; p = 0.037)), but high ABI was not associated with CKD (aOR 1.45 (0.88 – 2.38, p = 0.147)). Conclusion: The prevalence of abnormal ankle brachial index is high among adult populations of Ghana and Nigeria, with and without CKD. The Marker of peripheral arterial disease, but not marker of arterial stiffness was associated with CKD. A longitudinal study is required to determine the true relationship between ABI and CKD in West Africa.
Authors
- Samuel Ajayi (ORCID: https://orcid.org/0000-0003-4395-9222)
- Rasheed Gbadegesin (ORCID: https://orcid.org/0000-0001-5641-6644)
- Ifeoma Ulasi (ORCID: https://orcid.org/0000-0001-7783-3025)
- Charlotte Osafo (ORCID: https://orcid.org/0000-0002-2648-626X)
- Rulan S. Parekh (ORCID: https://orcid.org/0000-0001-6313-5752)
- Timothy Olusegun Olanrewaju (ORCID: https://orcid.org/0000-0002-8944-4198)
- Adebowale Adeyemo (ORCID: https://orcid.org/0000-0002-3105-3231)
- Manmak Mamven (ORCID: https://orcid.org/0000-0003-3229-6689)
- Bamidele O. Tayo (ORCID: https://orcid.org/0000-0002-2277-3958)
- Fatiu A. Arogundade
- Babatund L Salako
- Yemi Raheem Raji
- Akololu O Ojo
- D. Adu
Institutions
- University of Nigeria (NG)
- National Institutes of Health (US)
- University of Ghana (GH)
- University of Kansas (US)
- University of Ibadan (NG)
- University of Toronto (CA)
- Loyola University Chicago (US)
- Hospital for Sick Children (CA)
- Women's College Hospital (CA)
- University Medical Center Utrecht (NL)
- National Human Genome Research Institute (US)
- Duke Medical Center (US)
- SickKids Foundation (CA)
- University of Ilorin Teaching Hospital (NG)
- Duke University Hospital (US)
- Obafemi Awolowo University (NG)
- University of Abuja (NG)
Publication Details
- Journal
- Journal of Hypertension
- Published
- 2024-09-01
- DOI
- https://doi.org/10.1097/01.hjh.0001063756.51784.01
- Primary Topic
- Peripheral Artery Disease Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00